AGP Executive Report
Last update: an hour agoRegulatory Crossroads: The DEA’s federal marijuana rescheduling hearing is over, but Michigan and Ohio businesses now face a long wait as post-hearing briefs are due Aug. 17 and the DEA’s final call could stretch into 2027. Federal Legal Push: Senators Booker, Schumer and Wyden reintroduced the Cannabis Administration and Opportunity Act to remove cannabis from the Controlled Substances Act and build a federal regulatory framework. State Market Watch: Arkansas medical cannabis sales slipped 2.6% to $140.3M in the first half of 2026, while patient cards rose 7.7% to 119,074. Local Implementation: San Francisco approved cannabis cafés that can serve food and non-alcoholic drinks with on-site consumption and health-code requirements. Hemp Product Fight: A coalition of hemp businesses sued to block Missouri’s ban on intoxicating hemp products, arguing definitions are unconstitutionally vague. Medical Innovation: Leiutis Pharmaceuticals says CDSCO approved a synthetic CBD oral solution for mild-to-moderate anxiety with CBT. Safety Abroad: Thailand’s new customs rule warns travelers could face up to 10 years in prison for cannabis in luggage without proper permissions. Clinical Signal: A late-stage dementia study reported THC/CBD reduced agitation versus placebo through 12 weeks.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
